EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Prognostic Significance of Pretreatment Blood‐Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan

Shuichi Tatarano iD, Makito Miyake iD, Yu Osaki iD, Kei Daizumoto, Koichiro Wada, Keita Kobayashi iD, Minoru Kato, Hideo Fukuhara, Takuya Tsujino iD, Kohei Kobatake iD, Rikiya Taoka, Junya Furukawa und 9 weitere

International Journal of Urology · 2026-05 · 33 (5)

DOI: 10.1111/iju.70507 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, online erschienen am 20.05.2026. Verfasst von Shuichi Tatarano und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Biomarkers, Tumor, Penile Neoplasms, Serpins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Penile cancer is a rare malignancy, and multicenter data evaluating prognostic biomarkers in the Japanese population are limited. This study aimed to assess the prognostic significance of pretreatment blood‐based biomarkers in patients with penile cancer.

Methods

We conducted a multicenter retrospective cohort study including 111 patients with penile cancer treated between January 2005 and December 2023 at ten institutions participating in the West Japan Uro‐oncology Collaboration Group. Cancer–specific survival (CSS) was analyzed using the Kaplan–Meier method and Cox proportional hazards model. Receiver operating characteristic analyses were performed to determine optimal cutoff values for the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and squamous cell carcinoma antigen (SCC‐Ag). A composite biomarker score was calculated based on the number of elevated biomarkers.

Results

The 5‐year overall survival and CSS rates were 71.1% and 77.4%, respectively. In univariate analyses, elevated PLR, elevated SCC‐Ag, and higher composite biomarker scores were significantly associated with poorer CSS. In multivariate analysis, advanced clinical nodal status (≥ cN2) and distant metastasis (cM1) remained independent predictors of CSS, whereas blood‐based biomarkers did not retain independent prognostic significance after adjustment for established clinicopathological factors. Kaplan–Meier analyses demonstrated significantly worse CSS in patients with high PLR, high SCC‐Ag levels, and higher composite biomarker scores.

Conclusions

Pretreatment blood‐based biomarkers, particularly PLR and SCC‐Ag, are associated with prognosis in penile cancer. Although they did not retain independent prognostic factors after adjustment, these biomarkers may provide complementary prognostic information and help identify high‐risk patients in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmBiomarkers, TumorPenile NeoplasmsSerpinsAgedAged, 80 and overHumansMaleMiddle AgedJapanKaplan-Meier EstimateLymphocyte CountNeutrophilsPlatelet CountPrognosisRetrospective StudiesSurvival Rate

Stichwörter der Autor:innen

NLRPLRSCC‐agblood‐based biomarkerspenile cancer

Substanzen

Antigens, NeoplasmBiomarkers, TumorSerpinssquamous cell carcinoma-related antigen

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Department of Urology, Nara Medical University, Kashihara, Japan.
  • Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan.
  • Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Department of Urology, Shimane University Faculty of Medicine, Izumo, Japan.
  • Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.

ORCID-Profile: Shuichi Tatarano, Makito Miyake, Yu Osaki, Keita Kobayashi, Takuya Tsujino, Kohei Kobatake, Ryoichi Maenosono, Yohei Sekino

Zitieren

APA

Tatarano, S., Miyake, M., Osaki, Y., Daizumoto, K., Wada, K., Kobayashi, K., Kato, M., Fukuhara, H., Tsujino, T., Kobatake, K., Taoka, R., Furukawa, J., Ogawa, K., Shiraishi, K., Matsue, T., Inoue, K., Maenosono, R., Sekino, Y., Fujimoto, K., …, & West Japan Uro‐oncology Collaboration Group (2026). Prognostic Significance of Pretreatment Blood‐Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan. International Journal of Urology, 33(5). https://doi.org/10.1111/iju.70507

Vancouver

Tatarano S, Miyake M, Osaki Y, Daizumoto K, Wada K, Kobayashi K, et al. Prognostic Significance of Pretreatment Blood‐Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan. International Journal of Urology. 2026;33(5). doi:10.1111/iju.70507

BibTeX
@article{Tatarano2026,
  author = {Tatarano, Shuichi and Miyake, Makito and Osaki, Yu and Daizumoto, Kei and Wada, Koichiro and Kobayashi, Keita and Kato, Minoru and Fukuhara, Hideo and Tsujino, Takuya and Kobatake, Kohei and Taoka, Rikiya and Furukawa, Junya and Ogawa, Kohei and Shiraishi, Koji and Matsue, Taisuke and Inoue, Keiji and Maenosono, Ryoichi and Sekino, Yohei and Fujimoto, Kiyohide and Enokida, Hideki and West Japan Uro‐oncology Collaboration Group, West Japan Uro‐oncology Collaboration Group},
  title = {Prognostic Significance of Pretreatment Blood‐Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1111/iju.70507}
}
Kostenlos starten →